*Anything posted on this account not a financial advice.
#OpenAI #Anthropic #ScaleAI #Google #Meta #Cohere #AI21Labs #StabilityAI #xAI #Microsoft #Amazon #CharacterAI #ElevenLabs #InflectionAI #PerplexityAI
#OpenAI #Anthropic #ScaleAI #Google #Meta #Cohere #AI21Labs #StabilityAI #xAI #Microsoft #Amazon #CharacterAI #ElevenLabs #InflectionAI #PerplexityAI
• Intel has appointed Microchip CEO Steve Sanghi and former ASML CEO Eric Meurice to its board of directors.
• Co-CFO David Zinsner reaffirmed Intel’s Q3 guidance and emphasized its core strategy, including transforming Intel into a “world-class foundry.”
• Intel has appointed Microchip CEO Steve Sanghi and former ASML CEO Eric Meurice to its board of directors.
• Co-CFO David Zinsner reaffirmed Intel’s Q3 guidance and emphasized its core strategy, including transforming Intel into a “world-class foundry.”
I think this is enough to tell a story.
I think this is enough to tell a story.
Citron pounding the table that $NBIS is poised to be the next Al Wall Street darling. A sleeper with no analyst coverage yet, the market hasn't caught on to its massive potential-or its undervaluation vs.
CoreWeave. If it trades at a 50% discount to Coreweave multiple that puts $NBIS at $60
Citron pounding the table that $NBIS is poised to be the next Al Wall Street darling. A sleeper with no analyst coverage yet, the market hasn't caught on to its massive potential-or its undervaluation vs.
CoreWeave. If it trades at a 50% discount to Coreweave multiple that puts $NBIS at $60
1. TSM monthly earns, bc this will tell us the # of Blackwell orders for NVDA
2. Pfizer present their study at ASH meeting for AFFINE trial SGMO
3. DE court date 4 $SGMO
4.Pfizer will present gene therapy hemophilia $SGMO 🤝
What stock I should talk about next ?
1. TSM monthly earns, bc this will tell us the # of Blackwell orders for NVDA
2. Pfizer present their study at ASH meeting for AFFINE trial SGMO
3. DE court date 4 $SGMO
4.Pfizer will present gene therapy hemophilia $SGMO 🤝
What stock I should talk about next ?